Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts

• Li Liu,

  Affiliation Cancer Imaging Program, Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Haley Beck,

  Affiliation Cancer Imaging Program, Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Xiaolei Wang,

  Affiliation School of Pharmacy, Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America

  ⨯
• Hsing-Pang Hsieh,

  Affiliation Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei, Taiwan, Republic of China

  ⨯
• Ralph P. Mason ,

  * E-mail: xinli.liu@ttuhsc.edu (XL); ralph.mason@utsouthwestern.edu (RPM)

  Affiliation Cancer Imaging Program, Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Xinli Liu

  * E-mail: xinli.liu@ttuhsc.edu (XL); ralph.mason@utsouthwestern.edu (RPM)

  Affiliation School of Pharmacy, Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America

  ⨯